ESPE Abstracts (2023) 97 P1-348

ESPE2023 Poster Category 1 Pituitary, Neuroendocrinology and Puberty (73 abstracts)

Clinical course and genetic analysis in patients with childhood-onset congenital combined pituitary hormone deficiency

Yoon Ha Lee 1 , Ka Young Kim 2 , Da Hye Lee 3 , Min Jee Kim 4 , Yun Jeong Lee 5 , Young Ah Lee 5 , Jung Min Ko 5 & Choong Ho Shin 5

1Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do, Korea, Republic of. 2Catholic Kwandong University International St. Mary's Hospital, Gyeonggi-do, Korea, Republic of. 3Jungang Univeristy hospital, Seoul, Korea, Republic of. 4Dongguk University Ilsan hospital, Gyeonggi-do, Korea, Republic of. 5Seoul National University Children's Hospital, Seoul, Korea, Republic of

Background: Congenital combined pituitary hormone deficiency (CPHD) has various clinical presentations and can be caused by genetic defects related to pituitary development. We investigated the clinical features and genetic analysis in Korean patients with congenital CPHD.

Method: Among 444 patients diagnosed with CPHD between 1994 and 2021 from Seoul National University Children’s Hospital, 43 patients with congenital CPHD were included, after excluding 401 with acquired causes. Data on birth history, anthropometrics, hormonal evaluation, brain magnetic resonance imaging(MRI) findings, extra-pituitary phenotypes, and adulthood outcomes were collected. Next generation sequencing(NGS) analysis was performed in 24 patients using targeted exome (n= 18) or whole exome sequencing (n= 6).

Result: Median age of diagnosis was 2.0 (range, 0-14) years, and 18 (41.9%) were diagnosed 1 year of age. Mean height z-score at diagnosis was -2.4±3.8. Initial presentation at diagnosis were neonatal features suggesting hypopituitarism such as jaundice, hypoglycemia, and micropenis/cryptorchidism in 18 (41.9%), and short stature in 16 (37.2%). Despite suspicious presentation in neonatal period, 8 were diagnosed at later age (range, 1-13 years). Extra-pituitary phenotypes were shown in 31 (72.1%); developmental delay in 15 (34.9%), visual disorder in 9 (20.9%), or others. Growth hormone deficiency was most common (42, 97.7%), followed by thyroid stimulating hormone, adrenocorticotropic hormone, gonadotropin, and anti-diuretic hormone deficit in order. Brain MRI was done in 41 patients, and 33 (80.5%) had abnormalities including pituitary gland ectopia/hypoplasia/aplasia and thin pituitary stalk/aplasia. Those with MRI abnormalities had higher number of hormone deficiencies (P for trend 0.049) than those without. Height and metabolic outcomes were evaluated in 17 adult patients, final height z-scores was -0.8±1.9, and 8 (47.1%) had dyslipidemia without other metabolic disturbances. Pathogenic or likely pathogenic variants were detected in 6 (25%) patients; 1 POU1F1, 1 GLI2, 1 HESX1, 1 TBC1D32 and 2 ROBO1.

Conclusion: Considering high proportion of neonatal presentation, it is important to early identify suspicious symptoms related to hypopituitarism to early manage pituitary and extra-pituitary phenotypes. Detection rate of genetic variant using NGS was 25%, and genetic causes in congenital hypopituitarism remain to be further determined.

Volume 97

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sep 2023 - 23 Sep 2023

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.